Table 2.
Prognostic relevance of clinicopathological variables for overall survival.
| Variables | Patients (n) | Patients (%) | Mean survival months | 95% CL | P values |
|---|---|---|---|---|---|
| Gender | |||||
| Female | 21 | 52.5 | 8.0 | 4.89–11.11 | 0.350 |
| Male | 19 | 47.5 | 7.0 | 5.82–8.18 | |
|
| |||||
| Age (years) | |||||
| <60 | 10 | 25.0 | 8.0 | 5.61–10.39 | 0.580 |
| ≥60 | 30 | 75.0 | 7.0 | 5.29–8.71 | |
|
| |||||
| Number of bone metastases | |||||
| Single | 8 | 20.0 | 8.0 | 5.32–10.68 | 0.748 |
| Multiple | 32 | 80.0 | 7.0 | 5.56–8.44 | |
|
| |||||
| ECOG scores∗ | |||||
| 0–2 | 12 | 30.0 | 12 | 7.61–16.39 | 0.007 |
| 3–4 | 28 | 70.0 | 7 | 5.49–8.51 | |
|
| |||||
| Chemotherapy∗ | |||||
| No | 17 | 42.5 | 6.0 | 3.20–8.80 | 0.032 |
| Yes | 23 | 57.5 | 8.0 | 5.22–10.78 | |
|
| |||||
| Visceral metastasis∗ | |||||
| No | 8 | 20.0 | 12.0 | 9.849–14.15 | 0.002 |
| Yes | 32 | 80.0 | 7.0 | 5.87–8.13 | |
∗ P＜0.05, indicating statistical significance.